Detalhe da pesquisa
1.
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Support Care Cancer
; 24(7): 2837-42, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26838019
2.
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 17(6): 916-22, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20932925
3.
Safe Handling of Hazardous Drugs: ASCO Standards.
J Clin Oncol
; 37(7): 598-609, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30620670
4.
Novel treatment strategies for chronic myeloid leukemia.
Am J Health Syst Pharm
; 63(23 Suppl 8): S15-20; quiz S21-2, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17106016
5.
Pharmacology of anticancer agents in the elderly: the pharmacist's perspective.
Oncology (Williston Park)
; 23(1): 88, 90, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19283927
6.
Observations of second primary malignancy in patients with multiple myeloma.
Clin Lymphoma Myeloma Leuk
; 12(2): 113-7, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22178548
7.
Iron chelation therapy in myelodysplastic syndromes.
Am J Health Syst Pharm
; 67(7 Suppl 2): S10-4; quiz S16, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20332500
8.
Iron overload in myelodysplastic syndromes. Introduction.
Am J Health Syst Pharm
; 67(7 Suppl 2): S2, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20332502